VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the "Company" or "MedBright AI") (CSE:MBAI, OTCQB:MBAIF, FSE:1V7)) has announced today that it has achieved its near term goal of total clinic revenue under management with MedMatrix, the AI-powered data analytics platform.
14 clinics in total across the US and Canada, representing an estimated US$100M in total clinic revenue1, are now using MedMatrix.
"The adoption of MedMatrix has been extraordinary, with multiple clinic groups signing on in just two short months," said Dr. Jaime Gerber, Chairman of MedBright AI. "We look forward to continued expansion to many more clinic groups and continuing our rapid growth trajectory."
MedBright AI is the primary shareholder in MedMatrix, an AI-powered data analytics platform. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of healthcare facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside healthcare professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes.
About MedBright AI Investments Inc.
MedBright AI is a capital allocator focused on investing in healthcare technology companies. The team at MedBright prides themselves on unparalleled access to opportunities, as well as structuring unique and advantageous investments. MedBright's mission is to ...